Table 1.
The preoperative and postoperative features of the chemically injured cases in whom living-related conjunctival limbal or keratolimbal allograft (lr-CLAL or KLAL) transplantation was applied
| Case number | Laterality | HLA compatibility (+/−) | Surgical indication | Surgical technique and placements of the grafts | Epithelial recovery time (days) | Donor | Follow-up time after LT (months) |
|---|---|---|---|---|---|---|---|
| 1 | OS | - | PED | AMT | 25 | ||
| PED | Lr-CLAL (superior + inferior) | 20 | Brother | ||||
| CONJ | KLAL (superior + inferior) | 38 | |||||
| 2 | OS | - | CONJ | Lr-CLAL (superior + inferior) | 25 | Brother | 129 |
| PED + CO | KLAL (IN) + PK + ECCE | 6 | |||||
| CONJ | Lr-CLAL (SN) | 3 | Mother | ||||
| 3 | OD | - | CONJ | Lr-CLAL (superior + inferior) | - | Mother | 134 |
| 4 | OD | - | PED | Eyelid reconstruction | 138 | ||
| PED | Lr-CLAL (superior + inferior) + AMT | 23 | Brother | ||||
| PED + CO | KLAL (inferior) + PK + AMT | 51 | |||||
| 5 | OD | - | CONJ | Lr-CLAL (superior + inferior) + punctum diathermy | 120 | Mother | 151 |
| CO | PK + ECCE + IOL | ||||||
| 6 | OS | - | PED + CONJ | Lr-CLAL (superior + inferior) + AMT | - | Father | 68 |
| OD | - | CONJ | Lr-CLAL (superior + inferior) | 46 | Father | 68 | |
| CONJ | KLAL (nasal + temporal) + PK | 10 | |||||
| PED + CONJ | Lr-CLAL (superior + inferior) + AMT | 13 | Father | ||||
| 7 | OD | - | CO | Lr-CLAL (ST + IT) | 15 | Mother | 113 |
| PED | AMT | ||||||
| PED + CONJ | KLAL (nasal) + PK | 3 | |||||
| PED | Lr-CLAL (ST + IT) | 65 | Mother | ||||
| 2° glaucoma | Ahmed valve implantation PHACO + IOL | ||||||
| 8 | OD | - | CONJ | lr-CLAL (ST + IT) | 20 | Brother | 122 |
| CO | PK | ||||||
| 2° glaucoma | Peripheral iridectomy | ||||||
| CONJ | Lr-CLAL (superior) | 22 | Brother | ||||
| 9 | OS | + | Eyelid reconstruction | 48 | |||
| PED + CONJ | Lr-CLAL (superior + inferior) + AMT | 73 | Brother | ||||
| OD | + | Eyelid reconstruction | 48 | ||||
| PED + CONJ | Lr-CLAL (superior + inferior) + AMT | 41 | Brother | ||||
| Semblepharon | Semblepharon excision | ||||||
| Semblepharon | AMT + semblepharon excision | ||||||
| 10 | OS | - | CONJ | Lr-CLAL (SN + inferior) | 19 | Cousin | 122 |
| CO | PK | ||||||
| PED | Punctum diathermy PHACO + IOL | ||||||
| PED | Tarsorrhaphy | ||||||
| PED | KLAL (superior) + PK | 3 | |||||
| 11 | OD | - | CONJ + PED | Lr-CLAL (superior + inferior) + tarsorafi | - | Sister | 96 |
| CM | PK + ECCE + IOL | 41 | |||||
| OS | - | CONJ | Lr-CLAL (ST + IT) | 19 | Brother | 96 | |
| CONJ + CO | PK + semblepharon excision | ||||||
| CO | PK | ||||||
| 2° glaucoma | Diode laser cyclophotocoagulation | ||||||
| 12 | OD | - | CONJ + PED | Lr-CLAL (superior + inferior) + AMT | 14 | Sister | 75 |
| PED | PK + PHACO + IOL | ||||||
| Lr-CLAL (ST) + punctum diathermy | 10 | Father | |||||
| 13 | OD | + | CONJ | Lr-CLAL (superior + inferior) | 59 | Brother | 38 |
| CO | PK | ||||||
| Eyelid reconstruction | |||||||
| CONJ | KLAL (SN) | 5 | |||||
| 14 | OD | - | CONJ | Eyelid reconstruction | 12 | - | 109 |
| KLAL (superior + inferior) + PK + ECCE | |||||||
| OS | - | CONJ | KLAL (superior + inferior) + PK + ECCE + IOL | 10 | - | 109 |
HLA: Human leukocyte antigen, LT: Limbal transplantation, OS: Oculus sinister, OD: Oculus dexter, PED: Persistant epithelial defect, CONJ: Conjunctivalization, CO: Corneal opacification, 2°: Secondary, CM: Corneal melting, AMT: Amniotic membrane transplantation, Lr-CLAL: Living-related conjunctival limbal allograft, KLAL: Keratolimbal allograft, PK: Penetrating keratoplasty, ECCE: Extracapsular cataract extraxtion, IN: Inferior nasal, SN: Superior nasal, IOL: Intraocular lens, ST: Superior temporal, IT: Inferior temporal, PHACO: Phacoemulsification